# An efficiency analysis of high-order combinations of gene–gene interactions using multifactor-dimensionality reduction

- Cheng-Hong Yang
^{1}, - Yu-Da Lin
^{1}, - Cheng-San Yang
^{2}and - Li-Yeh Chuang
^{3}Email author

**Received: **21 February 2015

**Accepted: **24 June 2015

**Published: **1 July 2015

## Abstract

### Background

Multifactor dimensionality reduction (MDR) is widely used to analyze interactions of genes to determine the complex relationship between diseases and polymorphisms in humans. However, the astronomical number of high-order combinations makes MDR a highly time-consuming process which can be difficult to implement for multiple tests to identify more complex interactions between genes. This study proposes a new framework, named fast MDR (FMDR), which is a greedy search strategy based on the joint effect property.

### Results

Six models with different minor allele frequencies (MAFs) and different sample sizes were used to generate the six simulation data sets. A real data set was obtained from the mitochondrial D-loop of chronic dialysis patients. Comparison of results from the simulation data and real data sets showed that FMDR identified significant gene–gene interaction with less computational complexity than the MDR in high-order interaction analysis.

### Conclusion

FMDR improves the MDR difficulties associated with the computational loading of high-order SNPs and can be used to evaluate the relative effects of each individual SNP on disease susceptibility. FMDR is freely available at http://bioinfo.kmu.edu.tw/FMDR.rar.

### Keywords

SNPs Gene–gene interactions Multifactor dimensionality reduction## Background

Large single nucleotide polymorphisms (SNPs) research projects across the human genome are important studies for biological and biomedical science, with many researchers seeking to use SNPs as predictors for susceptibility to disease. Traditional approaches to identify SNP interactions usually use bio-statistical methods such as contingency tables combined with *k*-fold cross-validation, but the vast number of possible combinations makes the application of traditional methods difficult. Therefore, current research is aimed at combining biostatistics and machine learning in family-based and case–control association studies [1–8].

Multifactor dimensionality reduction (MDR) [9] is a well-known hybrid technology that combines a 2-way contingency table, *k*-fold cross-validation, and a dimensionality reduction technique. MDR belongs to a group of non-parametric statistical methods used to determine high-order gene–gene interactions in case–control studies [9, 10]. Typically, multi-locus genotypes are classified into high-risk and low-risk classes, allowing the number of genotype predictors to be effectively reduced from *n* dimensions to one dimension. This reduction influences the contingency table allowing for the quick computation of statistics including the accuracy rate, odds ratio (*OR*), *P*-value, etc. Many modifications and extensions to MDR have been proposed and these can be divided into three groups. The first group contains modifications and combinations of biostatistics in MDR; this group includes entropy-based interpretation methods [11], the use of *OR* [12], generalized linear models [13], log-linear methods [14], Bayesian posterior probability [15], and model-based methods [16]. The second group focuses on particular data problems, such as imbalanced data [17, 18], permutation testing [19], and missing data [20]. These extensions and modifications of MDR have been used to address different situations encountered in disease analysis. Many disease studies have thus successfully employed MDR to detect interactions between particular genes, including those for coronary artery disease [21, 22], hypertension [23–25], bladder cancer [26], and autism [27]. Finally, the third group aims to reduce MDR computational time, using methods including parallel implementations [28] and the use of hardware graphics processing units (GPUs) [29, 30]. Although these studies use GPUs to reduce MDR running time, the problem of factorial operation in MDR still presents a challenge.

This study seeks to develop a new framework to improve MDR computational times in investigations of high-order gene–gene interaction. The framework retains the significant factors to reduce the number of multi-locus evaluations in MDR. Improvements in computational time were measured over 100 runs on a simulation data set and a genome-wide analysis of chronic dialysis epistasis.

## Method

### MDR algorithm

*et al*. [17]. MDR can be divided into five separate processes. In the first step, the data are divided into 10 parts for ten-fold cross-validation. Nine-tenths of the data are classified as training sets and the remaining 1/10 is used for testing. The second step is the construction of a contingency table. For a given interaction order

*n*,

*n*SNPs are selected from the data set.

*L*is defined as a set of multi-locus genotypes at

*n*loci and/or environmental factors.

*L*can be represented as an

*n*-dimensional vector:

where *l* represents an SNP factor and/or environmental factor.

*L*is used to calculate the case–control ratios for each multi-locus genotype. The ratio between cases and controls is evaluated by Equation (2).

where the cases are labelled *P* and the controls are labelled *N. P*
^{*} and *N*
^{*} respectively represent the sizes of cases and controls in the training set. Here *j* represents the index of samples in the cases and controls. *P*
_{
j
} represents the *j*
^{th} sample among the cases and *N*
_{
j
} represents the *j*
^{th} sample among the controls. *u*(*L*, *P*
_{
j
}) represents a match (given a score of “1”) if all multi-locus genotypes *l* in vector *L* match *P*; a mismatch is given a score of “0”. *u*(*L*, *N*
_{
j
}) represents a match (given a score of “1”) if all multi-locus genotypes *l* in vector *L* match *N*; a mismatch is given a score of “0”. For example, a 2-order interaction model consisting of SNP1 and SNP2 has nine multi-locus genotypes, i.e., AA-AA, AA-Aa, AA-aa, Aa-AA, Aa-Aa, Aa-aa, aa-AA, aa-Aa and aa-aa. The AA represents the homozygous reference genotype, while Aa represents the heterozygous genotype and aa represents the homozygous variant genotype. In the first multi-locus genotype (AA-AA), the \( {\displaystyle {\sum}_{j=1}^{P^{*}}u\left(L,{P}_j\right)} \) includes 88 samples matching AA-AA among the cases and \( {\displaystyle {\sum}_{j=1}^{N^{*}}u\left(L,{N}_j\right)} \) includes 90 samples matching AA-AA among the controls. Evaluation with Eq. 2 yields a value of 0.978, which is computed by (88 × 300)/(90 × 300); *P*
^{*} and *N*
^{*} are respectively 300 samples among both the cases and controls.

*L*is labelled 'H' ("high") if the ratio of cases to controls is equal to or greater than a threshold of

*T*(=1); otherwise it is labelled 'L' ("low"). Once all

*L*s are labelled ‘H’ or ‘L’, a new binary attribute is created by pooling the high-risk genotype combinations into one group and the low-risk genotype combinations into another group. This means that the four frequencies (TP, FP, TN, and FN) can be computed in a 2-way contingency table. Finally, each possible

*L*computes a training classification error rate for each

*n*-way interaction in the training set. The classification error rate is given by Equation (3).

Among all *n* SNP combinations, the best model with the minimum classification error rate is selected by the training step. The third step evaluates the remaining 1/10 of the original data set (i.e., the independent test data). This step creates an MDR attribute for the testing set using the *n* SNPs that have the minimum training classification error rate. In addition, the best model in each cross-validation is collected and named the cross-validation consistency (CVC). In the fourth step, the procedure is repeated 10 times (i.e., ten-fold cross-validation) so that each sample is included in the testing set once, and the resulting classification error rates of each of the ten models in CVC are averaged. In the last step, the best MDR model with the highest frequency in CVC is selected.

### Fast MDR algorithm (FMDR)

*n*% combinations with the minimum classification error rate are saved into the

*i*

^{th}memory where

*i*is the

*i*

^{th}-fold cross-validation. When ten cross-validations are computed, the best 2-loci model is output to show related gene–gene interaction information. If the number of order exceeds two (i.e.,

*m*-loci,

*m*> 2), each cross-validation uses the corresponding memory and the recorded results of the best

*n*% combinations to create the available combinations (go to step (2)), i.e., conditions. In step (3), these conditions are evaluated using the contingency table, and the classification error rates of the conditions are estimated in step (4). The results are then sorted and the best

*n*% combinations are saved into

*i*

^{th}memory to analyze the next interaction order. This process tremendously reduces the number of available combinations. The processes are repeatedly implemented until the defined number of selected SNPs is analyzed.

### Illustrative example to FMDR and statistical analysis

The supplementary Additional file 1 provides an example to illustrate how the FMDR works, and the supplementary Additional file 2 explains the statistical analysis method.

## Results

### Results on the simulated data set

*n*-loci models with random architectures [31]. The settings and results of the six models are shown in Table 1. Figure 2 shows the power analysis box plots of six models. A summary of the six simulation data set shows that the difference between MDR and FMDR was statistically significant for 4-loci and 5-loci, but there was only a slight difference between the averages of the two methods.

A paired *t*-test comparison of the power analysis between MDR and FMDR for 2- to 5-loci

Model | 2-loci | 3-loci | 4-loci | 5-loci | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|

MDR | FMDR |
| MDR | FMDR |
| MDR | FMDR |
| MDR | FMDR |
| |

Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | |||||

Model 1 | 0.12 (±0.11) | 0.12 (±0.11) | − | 0.27 (±0.21) | 0.27 (±0.21) | − | 0.67 (±0.21) | 0.67 (±0.21) | 0.17 | 0.94 (±0.08) | 0.91 (±0.11) | <0.001 |

Model 2 | 0.05 (±0.00) | 0.05 (±0.00) | − | 0.24 (±0.18) | 0.24 (±0.18) | − | 0.78 (±0.14) | 0.78 (±0.14) | 0.65 | 0.96 (±0.04) | 0.96 (±0.05) | 0.001 |

Model 3 | 0.05 (±0.00) | 0.05 (±0.00) | − | 0.73 (±0.14) | 0.72 (±0.14) | 0.01 | 0.90 (±0.08) | 0.88 (±0.09) | 0.003 | 0.99 (±0.01) | 0.99 (±0.01) | <0.001 |

Model 4 | 0.24 (±0.10) | 0.24 (±0.10) | − | 0.50 (±0.14) | 0.50 (±0.14) | 0.32 | 0.88 (±0.09) | 0.87 (±0.09) | 0.01 | 0.99 (±0.02) | 0.98 (±0.03) | 0.001 |

Model 5 | 0.06 (±0.01) | 0.06 (±0.01) | − | 0.50 (±0.13) | 0.50 (±0.12) | 0.89 | 0.95 (±0.06) | 0.91 (±0.10) | <0.001 | 1.00 (±0.00) | 1.00 (±0.00) | − |

Model 6 | 0.05 (±0.00) | 0.05 (±0.00) | − | 0.11 (±0.04) | 0.11 (±0.04) | − | 0.70 (±0.12) | 0.70 (±0.12) | 0.001 | 1.00 (±0.00) | 1.00 (±0.00) | 0.001 |

*n*-loci (

*n*= 3, 4, 5) in model 1, the growth times between MDR and FMDR for 3-loci to 5-loci were 3.796

*vs*. 2.691, 38.279

*vs*. 8.712, and 424.18

*vs*. 43.260 (milliseconds). Similarly, Figure C1 of supplementary Additional file 3 compares the 2-loci and

*n*-loci in models 3–6. We compared the growth time between 800 and 1600 samples in different MAFs. For MAF = 0.1, MDR and FMDR for 2-loci to 5-loci were 1.162

*vs*. 1.197, 1.796

*vs*. 1.452, 2.140

*vs*. 1.599, and 2.063

*vs*. 1.774. Similarly, Figure D1 of supplementary Additional file 4 shows the growth times between MDR and FMDR in other MAFs (i.e., MAF = 0.2 and MAF = 0.4). The results for the simulation data sets showed that FMDR effectively reduces MDR computational time.

### Results on the chronic dialysis data set

The 77 mitochondrial SNPs in the D-loop region of chronic dialysis patients were obtained from investigations conducted by Chen *et al*. [32] that enrolled 193 chronic dialysis patients and 704 healthy controls from unrelated ethnic Chinese in Taiwan. The results revealed that chronic peritoneal dialysis patients suffer from higher oxidative stress than healthy subjects; this elevated oxidative stress alters the number of copies of mtDNA in peripheral leukocytes. The possible complicated networks with direct or indirect cross-communication among the 77 SNP candidates were explained. The ratio of controls (*n* = 704) to cases (*n* = 193) was 3.65:1. We randomly sorted the samples in the data set to generate 100 data sets each of which was then divided into ten groups for ten-fold cross-validation. The ratios of cases to controls amongst 1000 training sets range from 3.41–3.95, with a mean (SD) ratio of 3.65 (0.10). Each data set was used once to test MDR and FMDR.

*OR*of the best candidate model was evaluated. Table 2 shows the best, worst, and mean (±SD) in the 100 tests for MDR and FMDR. For the 3- –6-loci models producing the best accuracy amongst the 100 tests, both MDR and FMDR had the same candidate model, and also had the same accuracy and

*OR*. In the models for 3- to 6-loci with the lowest accuracy amongst the 100 tests, MDR and FMDR were different slightly, and the accuracy and

*OR*also differed. A box plot was used to compare the two methods for 3-, 4-, 5-, and 6-loci interactions. Figure 4a and b respectively shows the accuracy and

*OR*box plot of MDR and FMDR. Paired

*t*-test comparison results indicate that the accuracy and

*OR*values for 3- –6-loci analysis over 100 test runs were similar for both MDR and FMDR. Figure 4c shows the box plot of the power results of MDR and FMDR for four order interactions. As the order of interaction increases, both MDR and FMDR shows increasing power values. All powers of MDR and FMDR exceeded 0.8. A summary of the 100 test runs shows that the difference between MDR and FMDR was statistically significant for 3- and 6-loci, but the average difference between the two methods is very slight, i.e., −0.011 at 3-loci and 0.002 at 6-loci. In addition, the powers in the 4- and 5-loci analysis over 100 test runs are similar for both MDR and FMDR.

Analysis results of the chronic dialysis data sets from MDR and FMDR

Models | Method | 3-loci | 4-loci | 5-loci | 6-loci | ||||
---|---|---|---|---|---|---|---|---|---|

MDR | FMDR | MDR | FMDR | MDR | FMDR | MDR | FMDR | ||

Best | |||||||||

Candidate model | 40,56,64 | 40,56,64 | 21,59,64,71 | 21,59,64,71 | 21,59,62, 64,71 | 21,59,62, 64,71 | 21,45,59, 62,64,71 | 21,45,59, 62,64,71 | |

Consistency | 2 / 10 | 2 / 10 | 4 / 10 | 2 / 10 | 1 / 10 | 1 / 10 | 2 / 10 | 3 / 10 | |

Accuracy | 0.56 | 0.56 | 0.58 | 0.58 | 0.58 | 0.58 | 0.60 | 0.60 | |

| 1.79 | 1.79 | 1.91 | 1.91 | 2.13 | 2.13 | 2.30 | 2.30 | |

(1.27–2.52) | (1.27–2.52) | (1.38–2.63) | (1.38–2.63) | (1.54–2.94) | (1.54–2.94) | (1.66–3.18) | (1.66–3.18) | ||

Worst | |||||||||

candidate model | 45,56,62 | 45,56,65 | 40,45,56,62 | 19,21,34, 56 | 41,43,45, 56,62 | 40,56,64, 71,77 | 4,21,56, 60,62,70 | 40,21,56, 64,71,77 | |

Consistency | 1 / 10 | 1 / 10 | 2/10 | 1/10 | 1 / 10 | 1 / 10 | 1 / 10 | 1 / 10 | |

Accuracy | 0.56 | 0.56 | 0.57 | 0.56 | 0.57 | 0.57 | 0.58 | 0.59 | |

| 1.64 | 1.65 | 1.82 | 1.78 | 1.86 | 1.90 | 2.13 | 2.28 | |

(1.18–2.27) | (1.19–2.31) | (1.31–2.54) | (1.27–2.49) | (1.34–2.60) | (1.36–2.64) | (1.50–3.03) | (1.59–3.26) | ||

Accuracy | |||||||||

Mean (SD) | 0.56 (±0.00) | 0.56 (±0.00) | 0.58 (±0.01) | 0.58 (±0.01) | 0.58 (±0.002) | 0.58 (±0.002) | 0.60 (±0.01) | 0.60 (±0.01) | |

| − | 0.07 | 0.32 | 0.85 | |||||

| |||||||||

Mean (SD) | 1.73 (±0.05) | 1.73 (±0.05) | 2.04 (±0.19) | 2.03 (±0.19) | 2.21 (±0.18) | 2.17 (±0.19) | 2.31 (±0.08) | 2.30 (±0.08) | |

| 0.66 | 0.44 | 0.03 | 0.46 | |||||

Power | |||||||||

Mean (SD) | 0.97 (±0.03) | 0.99 (±0.02) | 0.99 (±0.02) | 0.99 (±0.02) | 0.99 (±0.003) | 0.99 (±0.002) | 0.99 (±0.004) | 0.99 (±0.003) | |

| <0.001 | 0.83 | 0.71 | <0.001 |

*n*-loci (

*n*= 3, 4, 5, 6), the growth times between MDR and FMDR are 10.40

*vs*. 5.95, 200.16

*vs*. 21.08, 2880.95

*vs*. 70.93, and 8081.88

*vs*. 245.81. These results ind-+icate that the proposed framework can reduce the execution times required by MDR for high-order interaction analysis.

## Discussion

The substantial computational limits of MDR make it difficult to detect nonlinear interactions of high-order combinations of SNPs amongst a large number of SNPs. Determining all combinations of SNPs in MDR entails calculating *C*(*N*,*M*) × *V* = *N*!/[*M*!(*N*-*M*)!] × *V* combinations, where *N* is the total number of SNPs, *M* is the number of factors considered for a model, and *V* is the number of cross-validation intervals. In big-O notation, MDR has a time complexity of O(n!).

Exhaustive search approaches, e.g., genetic algorithm (GA) [10] and ant colony optimization (ACO) [33] are important for improving MDR computational times. GA and ACO use small combinations to find the acceptable *n*-loci gene–gene interaction model in a huge combination space, thus effectively reducing the computational time requirements. However, all parameters can influence the results of detected gene–gene interaction. The parameters of population size, generation size, random seed, and algorithm setting (e.g., mutation probability in GA and pheromone in ACO) are difficult to define to successfully find the *n*-loci gene–gene interaction model for data sets of different sizes, i.e., sample size and SNP size. Therefore, current research directions focus on the use of software and hardware to improve MDR computational times.

Many researchers employ software [28] and hardware [29, 30] techniques to speed up MDR. Bush *et al*. proposed a framework which divides the MDR processes into three classes: (1) a data handling class, (2) a model generation and processing class, and (3) a result storage class. These three modular classes were implemented in parallel, finding that parallel MDR can be used to analyze high-order interactions of small data sets and can feasibly perform lower-end genome-wide analyses. Greene *et al*. and Sinnott-Armstrong *et al*. [29, 30] employed modern computer Graphics Processing Units (GPUs) to speed up MDR since GPUs have a higher memory bandwidth and computational capability than Central Processing Units (CPUs). Still, the factorial increase of time complexity remains an obstacle.

The FMDR procedure is a type of greedy search strategy [34], and is based on joint effect property [35]. The joint effect can be divided into the three effects: (1) overall effect, (2) *n*-order interaction effect, and (3) main effect. In epistasis, overall effect indicates the common effect amongst *n* risk factors. The main effect indicates any effect(s) could serve as a guide to determining the correct multi-locus interaction. The *n*-order interaction effect indicates the least proper subset of the loci also interacts epistatically. The highly-associated SNPs have a high probability of being a significant factor in the next-order interaction. A low classification error rate in an MDR model indicates a high statistically significant risk of *n*-loci effects. Suppose all 2-loci combinations in four SNPs are sorted according the classification error rate as {SNP_{a}, SNP_{b}}, {SNP_{b}, SNP_{c}}, {SNP_{a}, SNP_{c}}, {SNP_{a}, SNP_{d}}, …, {SNP_{b}, SNP_{d}}. The {SNP_{a}, SNP_{b}} is the best model in 2-loci gene–gene interaction. The {SNP_{b}, SNP_{c}} and {SNP_{a}, SNP_{c}} combinations are both probably significant models for gene–gene interaction, but neither is the best model. SNP_{c} has the highest probability of joining the 3-loci gene–gene interaction because it’s strong association with SNP_{a} and SNP_{b} (i.e., 2-order interaction effect). On the other hand, {SNP_{b}, SNP_{d}} is the worst model; it means that adding SNP_{d} via SNP_{b} into the gene–gene interaction network is the least likely scenario. SNP_{d} has a high probability of being added via the SNP_{a} effect because {SNP_{a}, SNP_{d}} belongs to the top model with a low classification error rate. Therefore, the {SNP_{b}, SNP_{d}} can be deleted, and all combinations based on {SNP_{b}, SNP_{d}} in 3-loci combination are not evaluated. These properties allow us to apply the greedy search strategy to find the significant gene–gene interaction model. Moreover, FMDR only sets one parameter to select the number of best combinations with the low classification error rate, which are then saved into the memory. We suggest the optimal choice for *n* is the dynamic adjustment according to the order of interaction, i.e., *n* = 2 with 2-order gene-gene interaction and *n* = 3 with 3-order gene-gene interaction.

The idea behind FMDR is the retention of good results for high-order interaction, indicating the available combinations are generated from *n*% good results, i.e., *n*% results × *N* combinations, where *N* is the total number of SNPs. Therefore, FMDR has a time complexity of O(n). The execution time of FMDR is much shorter than that of MDR in high-order gene–gene interactions because FMDR effectively decreases the number of possible unnecessary computations. FMDR includes the following advantages: (1) FMDR can effectively reduce the computational time required by MDR for high-order interactions, (2) the best model has a low classification error rate and a high sensitivity for disease prediction, and (3) FMDR can easily be combined with existing MDR methods.

## Conclusions

FMDR based on the joint effect property reduces MDR computational time by retaining results for higher interactions. The retained number of results can be formularized and improved using statistical methods and mathematic theories in future work. The time complexity can be easily computed by estimation of a function. We suggest that the function be designed as a dynamic adjustment based on the data set size and the order of interaction. The flexible framework underlying FMDR can effectively improve the limitations of existing MDR methods in finding high-order interactions.

## Declarations

### Acknowledgements

This study was partly supported by the National Science Council of Taiwan for Grant NSC 102-2221-E-151-024 -MY3, 102-2622-E-151-003-CC3, and 102-2221-E-214 -039.

## Authors’ Affiliations

## References

- Li X, Liao B, Chen H. A new technique for generating pathogenic barcodes in breast cancer susceptibility analysis. J Theor Biol. 2015;366:84–90.PubMedView ArticleGoogle Scholar
- Yang CH, Lin YD, Chuang LY, Chang HW. Evaluation of Breast Cancer Susceptibility Using Improved Genetic Algorithms to Generate Genotype SNP Barcodes. IEEE ACM T Comput Bi. 2013;10(2):361–71.Google Scholar
- Yang CH, Chuang LY, Cheng YH, Lin YD, Wang CL, Wen CH, et al. Single nucleotide polymorphism barcoding to evaluate oral cancer risk using odds ratio-based genetic algorithms. Kaohsiung J Med Sci. 2012;28(7):362–8.PubMedView ArticleGoogle Scholar
- Steen KV. Travelling the world of gene-gene interactions. Brief Bioinform. 2012;13(1):1–19.PubMedView ArticleGoogle Scholar
- Chuang LY, Lin YD, Chang HW, Yang CH. An improved PSO algorithm for generating protective SNP barcodes in breast cancer. PLoS One. 2012;7(5), e37018.PubMed CentralPubMedView ArticleGoogle Scholar
- Yang P, Ho JW, Yang YH, Zhou BB. Gene-gene interaction filtering with ensemble of filters. BMC Bioinformatics. 2011;12 Suppl 1:S10.PubMed CentralPubMedView ArticleGoogle Scholar
- Shang JL, Zhang JY, Sun Y, Liu D, Ye DJ, Yin YL. Performance analysis of novel methods for detecting epistasis. BMC Bioinformatics. 2011;12:475.PubMed CentralPubMedView ArticleGoogle Scholar
- Moore JH, Asselbergs FW, Williams SM. Bioinformatics challenges for genome-wide association studies. Bioinformatics. 2010;26(4):445–55.PubMed CentralPubMedView ArticleGoogle Scholar
- Ritchie MD, Hahn LW, Roodi N, Bailey LR, Dupont WD, Parl FF, et al. Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am J Hum Genet. 2001;69(1):138–47.PubMed CentralPubMedView ArticleGoogle Scholar
- Hahn LW, Ritchie MD, Moore JH. Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions. Bioinformatics. 2003;19(3):376–82.PubMedView ArticleGoogle Scholar
- Moore JH, Gilbert JC, Tsai CT, Chiang FT, Holden T, Barney N, et al. A flexible computational framework for detecting, characterizing, and interpreting statistical patterns of epistasis in genetic studies of human disease susceptibility. J Theor Biol. 2006;241(2):252–61.PubMedView ArticleGoogle Scholar
- Chung YJ, Lee SY, Elston RC, Park T. Odds ratio based multifactor-dimensionality reduction method for detecting gene-gene interactions. Bioinformatics. 2007;23(1):71–6.PubMedView ArticleGoogle Scholar
- Lou XY, Chen GB, Yan L, Ma JZ, Zhu J, Elston RC, et al. A generalized combinatorial approach for detecting gene-by-gene and gene-by-environment interactions with application to nicotine dependence. Am J Hum Genet. 2007;80(6):1125–37.PubMed CentralPubMedView ArticleGoogle Scholar
- Lee SY, Chung Y, Elston RC, Kim Y, Park T. Log-linear model-based multifactor dimensionality reduction method to detect genegene interactions. Bioinformatics. 2007;23(19):2589–95.PubMedView ArticleGoogle Scholar
- Li CF, Luo FT, Zeng YX, Jia WH. Weighted risk score-based multifactor dimensionality reduction to detect gene-gene interactions in nasopharyngeal carcinoma. Int J Mol Sci. 2014;15(6):10724–37.PubMed CentralPubMedView ArticleGoogle Scholar
- Calle ML, Urrea V, Vellalta G, Malats N, Steen KV. Improving strategies for detecting genetic patterns of disease susceptibility in association studies. Stat Med. 2008;27(30):6532–46.PubMedView ArticleGoogle Scholar
- Yang CH, Lin YD, Chuang LY, Chen JB, Chang HW. MDR-ER: balancing functions for adjusting the ratio in risk classes and classification errors for imbalanced cases and controls using multifactor-dimensionality reduction. PLoS One. 2013;8(11), e79387.PubMed CentralPubMedView ArticleGoogle Scholar
- Velez DR, White BC, Motsinger AA, Bush WS, Ritchie MD, Williams SM, et al. A balanced accuracy function for epistasis modeling in imbalanced datasets using multifactor dimensionality reduction. Gen Epidemiol. 2007;31(4):306–15.View ArticleGoogle Scholar
- Pattin KA, White BC, Barney N, Gui J, Nelson HH, Kelsey KT, et al. A Computationally efficient hypothesis testing method for epistasis analysis using multifactor dimensionality reduction. Gen Epidemiol. 2009;33(1):87–94.View ArticleGoogle Scholar
- Namkung J, Kim K, Yi S, Chung W, Kwon MS, Park T. New evaluation measures for multifactor dimensionality reduction classifiers in gene-gene interaction analysis. Bioinformatics. 2009;25(3):338–45.PubMedView ArticleGoogle Scholar
- Agirbasli M, Guney AI, Ozturhan HS, Agirbasli D, Ulucan K, Sevinc D, et al. Multifactor dimensionality reduction analysis of MTHFR, PAI-1, ACE, PON1, and eNOS gene polymorphisms in patients with early onset coronary artery disease. Eur J Cardiovasc Prev Rehabil. 2011;18(6):803–9.PubMedView ArticleGoogle Scholar
- Tsai CT, Hwang JJ, Ritchie MD, Moore JH, Chiang FT, Lai LP, et al. Renin-angiotensin system gene polymorphisms and coronary artery disease in a large angiographic cohort: Detection of high order gene-gene interaction. Atherosclerosis. 2007;195(1):172–80.PubMedView ArticleGoogle Scholar
- Moore JH, Williams SM. New strategies for identifying gene-gene interactions in hypertension. Ann Med. 2002;34(2):88–95.PubMedView ArticleGoogle Scholar
- Williams SM, Ritchie MD, Phillips JA, Dawson E, Prince M, Dzhura E, et al. Multilocus analysis of hypertension: A hierarchical approach. Hum Hered. 2004;57(1):28–38.PubMedView ArticleGoogle Scholar
- Sanada H, Yatabe J, Midorikawa S, Hashimoto S, Watanabe T, Moore JH, et al. Single-nucleotide polymorphisms for diagnosis of salt-sensitive hypertension. Clin Chem. 2006;52(3):352–60.PubMedView ArticleGoogle Scholar
- Gui J, Andrew AS, Andrews P, Nelson HM, Kelsey KT, Karagas MR, et al. A robust multifactor dimensionality reduction method for detecting gene–gene interactions with application to the genetic analysis of bladder cancersusceptibility. Ann Hum Genet. 2011;75(1):20–8.PubMed CentralPubMedView ArticleGoogle Scholar
- Coutinho AM, Sousa I, Martins M, Correia C, Morgadinho T, Bento C, et al. Evidence for epistasis between SLC6A4 and ITGB3 in autism etiology and in the determination of platelet serotonin levels. Hum Genet. 2007;121(2):243–56.PubMedView ArticleGoogle Scholar
- Bush WS, Dudek SM, Ritchie MD. Parallel multifactor dimensionality reduction: a tool for the large-scale analysis of gene-gene interactions. Bioinformatics. 2006;22(17):2173–4.PubMedView ArticleGoogle Scholar
- Sinnott-Armstrong NA, Greene CS, Cancare F, Moore JH. Accelerating epistasis analysis in human genetics with consumer graphics hardware. BMC Res Notes. 2009;2(1):149.PubMed CentralPubMedView ArticleGoogle Scholar
- Greene CS, Sinnott-Armstrong NA, Himmelstein DS, Park PJ, Moore JH, Harris BT. Multifactor dimensionality reduction for graphics processing units enables genome-wide testing of epistasis in sporadic ALS. Bioinformatics. 2010;26(5):694–5.PubMed CentralPubMedView ArticleGoogle Scholar
- Urbanowicz RJ, Kiralis J, Sinnott-Armstrong NA, Heberling T, Fisher JM, Moore JH. GAMETES: a fast, direct algorithm for generating pure, strict, epistatic models with random architectures. Biodata Min. 2012;5:16.PubMed CentralPubMedView ArticleGoogle Scholar
- Chen JB, Yang YH, Lee WC, Liou CW, Lin TK, Chung YH, et al. Sequence-based polymorphisms in the mitochondrial d-loop and potential SNP predictors for chronic dialysis. PLoS One. 2012;7(7):e41125.PubMed CentralPubMedView ArticleGoogle Scholar
- Greene CS, White BC, Moore JH: Ant colony optimization for genome-wide genetic analysis. In: Ant Colony Optimization and Swarm Intelligence. Springer; 2008:37–47Google Scholar
- Faigle U, Fujishige S. A general model for matroids and the greedy algorithm. Math Program. 2009;119(2):353–69.View ArticleGoogle Scholar
- Ye K. Experiments: Planning, analysis, and parameter design optimization. Interfaces. 2003;33(5):96–8.Google Scholar

## Copyright

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.